HEPATOCARCINOMA
Clinical trials for HEPATOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEPATOCARCINOMA trials appear
Sign up with your email to follow new studies for HEPATOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to make allergy testing safer for cancer patients on biologics
Knowledge-focused Recruiting nowThis study is testing how to safely perform skin allergy tests in people receiving biotherapies for cancers and blood disorders. Researchers will find the highest concentration of each biotherapy that does not cause a skin reaction in 9 out of 10 patients. The goal is to establis…
Matched conditions: HEPATOCARCINOMA
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple blood test predict liver cancer treatment success?
Knowledge-focused Recruiting nowThis study aims to find tiny genetic markers (microRNAs) and blood chemicals that can tell doctors early whether a liver cancer patient will fully respond to heat-based tumor destruction. Researchers will analyze blood and tumor tissue samples from 150 adults with early-stage liv…
Matched conditions: HEPATOCARCINOMA
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Scientists hunt for liver Cancer's immune escape secrets
Knowledge-focused Recruiting nowThis study looks at how liver cancer avoids being attacked by the immune system. Researchers will analyze tumor tissue and blood from 270 people with liver cancer to find specific molecules that help cancer hide. The goal is to better understand these escape mechanisms, which cou…
Matched conditions: HEPATOCARCINOMA
Sponsor: Niguarda Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New liver risk scores aim to predict who needs closer monitoring
Knowledge-focused Recruiting nowThis study is testing two scoring methods (PLEASE and M10S20) to see if they can better predict serious liver events, liver cancer, and death in 600 people with advanced chronic liver disease. Participants are randomly assigned to standard care or a risk-based monitoring schedule…
Matched conditions: HEPATOCARCINOMA
Sponsor: University Hospital Muenster • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC